(EMAILWIRE.COM, December 08, 2018 ) The global metabolomics market is estimated to reach USD 2.39 billion by 2021, at a CAGR of 14.6% during the forecast period. The growing acceptance of metabolomics for personalized medicine, increasing pharmaceutical and biotech R&D expenditure, and continuous technological advancements are some of the factors driving market growth.

Ask For Discount: https://www.marketsandmarkets.com/discountreports.asp?id=900

New range of enhanced technologies for accuracy and precision in metabolomics research and growth in emerging markets due to increasing investments presents significant growth opportunities for players in the market. However, issues related to data examination and processing and high-cost tools and instruments and their maintenance are the major restraining factors for this market.

The report analyzes the metabolomics market by product & service, application, indication, and region. The research report discusses key market drivers, restraints, opportunities, and challenges in the global metabolomics market and its submarkets. Based on product & service, the market is segmented into metabolomics instruments and metabolomics bioinformatics tools & services.

Metabolomics bioinformatics tools & services is expected to grow at the highest CAGR during the forecast period. The ability of metabolome analysis software tools for interpreting the results of analytical experiments and understand the potential of metabolomics data generated from analytical tools are expected to drive the growth of this segment.

Read Full Research Report: https://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html